BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7771055)

  • 1. Immunoreactivity of canine epithelial and nonepithelial neoplasms with monoclonal antibody B72.3.
    Clemo FA; DeNicola DB; Morrison WB; Carlton WW
    Vet Pathol; 1995 Mar; 32(2):147-54. PubMed ID: 7771055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical evaluation of canine carcinomas with monoclonal antibody B72.3.
    Clemo FA; DeNicola DB; Delaney LJ
    Vet Pathol; 1993 Mar; 30(2):140-5. PubMed ID: 8470336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactivity of canine transitional cell carcinoma of the urinary bladder with monoclonal antibodies to tumor-associated glycoprotein 72.
    Clemo FA; DeNicola DB; Carlton WW; Walker E; Morrison WB
    Vet Pathol; 1995 Mar; 32(2):155-61. PubMed ID: 7771056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of immunoreactivity of normal tissues from dogs, using monoclonal antibody B72.3.
    Clemo FA; DeNicola DB; Zimmermann JL
    Am J Vet Res; 1994 Aug; 55(8):1139-47. PubMed ID: 7978655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactivity of canine mammary neoplasms with monoclonal antibody CC49.
    Shahar R; Harmelin A; Shamir MH; Schneebaum S
    Zentralbl Veterinarmed A; 1997 Aug; 44(6):317-23. PubMed ID: 9342924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
    Johnston WW
    Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of immunocytochemistry to clinical cytology.
    Johnston WW; Szpak CA; Thor A; Simpson JF; Schlom J
    Cancer Invest; 1987; 5(6):593-611. PubMed ID: 3327572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.
    Johnston WW; Szpak CA; Thor A; Schlom J
    Cancer Res; 1986 Dec; 46(12 Pt 1):6462-70. PubMed ID: 3022920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated glycoprotein expression in salivary gland mucoepidermoid carcinomas: an immunohistochemical study using the monoclonal antibody B72.3.
    Roa RA; Hruban RH; McKenzie P; Richtsmeier W
    Laryngoscope; 1994 Mar; 104(3 Pt 1):304-8. PubMed ID: 8127187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3.
    Thor A; Ohuchi N; Szpak CA; Johnston WW; Schlom J
    Cancer Res; 1986 Jun; 46(6):3118-24. PubMed ID: 3516392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of B72.3 with adenocarcinomas. An immunohistochemical study of 476 cases.
    Loy TS; Nashelsky MB
    Cancer; 1993 Oct; 72(8):2495-8. PubMed ID: 8402466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
    Molinolo A; Simpson JF; Thor A; Schlom J
    Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
    Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
    J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.
    Muraro R; Kuroki M; Wunderlich D; Poole DJ; Colcher D; Thor A; Greiner JW; Simpson JF; Molinolo A; Noguchi P
    Cancer Res; 1988 Aug; 48(16):4588-96. PubMed ID: 3396010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical staining and radionuclide imaging of canine tumors, using a monoclonal antibody recognizing a synthetic carbohydrate antigen.
    Haines DM; Matte G; Wilkinson AA; Noujaim AA; Turner C; Longenecker BM
    Am J Vet Res; 1989 Jun; 50(6):875-81. PubMed ID: 2548421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementation of anti-CEA and anti-TAG-72 monoclonal antibodies in reactivity to human gastric adenocarcinomas.
    Ohuchi N; Simpson JF; Colcher D; Schlom J
    Int J Cancer; 1987 Dec; 40(6):726-33. PubMed ID: 2447021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a monoclonal antibody (B72.3) as a novel immunohistochemical adjunct for the diagnosis of carcinomas in fine needle aspiration biopsy specimens.
    Johnston WW; Szpak CA; Lottich SC; Thor A; Schlom J
    Hum Pathol; 1986 May; 17(5):501-13. PubMed ID: 2422108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated glycoprotein (TAG-72) detected in adenocarcinomas and benign lesions of the stomach.
    Ohuchi N; Thor A; Nose M; Fujita J; Kyogoku M; Schlom J
    Int J Cancer; 1986 Nov; 38(5):643-50. PubMed ID: 2429933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivity of the monoclonal antibody B72.3 with fetal antigen: correlation with expression of TAG-72 in human carcinomas.
    Stanick D; Schuss A; Mishriki Y; Chao S; Thor A; Lundy J
    Cancer Invest; 1988; 6(3):279-87. PubMed ID: 3048576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface expression of tumor-associated antigens in primary cultured human colonic epithelial cells from carcinomas, benign tumors, and normal tissues.
    Friedman E; Thor A; Hand PH; Schlom J
    Cancer Res; 1985 Nov; 45(11 Pt 2):5648-55. PubMed ID: 2413994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.